Skip to main content
ACS Omega logoLink to ACS Omega
. 2020 Jun 2;5(23):13902–13912. doi: 10.1021/acsomega.0c01277

H-Bond Surrogate-Stabilized Shortest Single-Turn α-Helices: sp2 Constraints and Residue Preferences for the Highest α-Helicities

Sunit Pal 1, Shreya Banerjee 1, Ankur Kumar 1, Erode N Prabhakaran 1,*
PMCID: PMC7301546  PMID: 32566857

Abstract

graphic file with name ao0c01277_0012.jpg

Short α-helical sequences of proteins fail to maintain their native conformation when taken out of their protein context. Several covalent constraints have been designed, including the covalent H-bond surrogate (HBS)—where a peptide backbone i + 4 → i H-bond is replaced by a covalent surrogate—to nucleate α-helix in short sequences (>7 < 15 amino acids). But constraining the shortest sequences (four amino acids) into a single α-helical turn is still a significant challenge. Here, we introduce an HBS model that can be placed in unstructured tetrapeptides without excising any of its residues, and that biases them predominantly into remarkably stable single α-helical turns in varying solvents, pH values, and temperatures. Circular dichroism (CD), Fourier transform infrared (FT-IR) absorption, one-dimensional (1D)-NMR, two-dimensional (2D)-NMR spectral and computational analyses of the HBS-constrained tetrapeptide analogues reveal that (a) the number of sp2 atoms in the HBS-constrained backbone influences their predominance and rigidity in the α-helical conformation; and (b) residue preferences at the unnatural HBS-constrained positions influence their α-helicities, with Moc[GFA]G-OMe (1a) showing the highest known α-helicity (θn→π*MRE ∼−25.3 × 103 deg cm2 dmol–1 at 228 nm) for a single α-helical turn. Current findings benefit chemical biological applications desiring predictable access to single α-helical turns in tetrapeptides.

Introduction

α-Helical sequences of ≤15 amino acids are key components of protein structure and function.111 Single α-helical turns1216 in shorter sequences (four to six amino acids) also influence several biological activities in protein active sites, molecular recognition, protein–DNA interactions, and protein folding.11,1723 Hence, synthesizing single α-helical turn mimics has immense potential for biological applications. The problem however is that α-helices composed of ≤15 amino acids lack sufficient enthalpy from contiguous weak i + 4 → i backbone hydrogen bonds or i + 4···i inter-side-chain interactions, to counter the significantly high backbone unfolding entropy.14,2426 This enthalpy–entropy imbalance increases inversely with decreasing chain length and is the highest in tetrapeptides where only one i + 4 → i H-bond is possible. Tetrapeptides hence typically exist as random coils. Various structural modifications have been designed to overcome this entropic disfavor and to create a proclivity for the α-helical conformation in short peptides. These include the use of helix-nucleating templates,10,2733 unnatural amino acids,21,3436 metal clamps,3744 noncovalent4548 and covalent4,6,7,12,4955 side-chain linkers, and covalent hydrogen-bond surrogates (HBSs).52,5659 Among these, the HBS strategy presents the advantage of not perturbing the native side-chain molecular recognition surface, which is essential for eventual functional mimicry. But an efficient HBS model is yet to be designed for constraining tetrapeptides in single α-helical turns with predictable high helicities.

The HBS strategy involves replacement of the labile main-chain hydrogen bonds with a covalent surrogate52 (Figure 1). The single α-helical turn is a 13-membered ring with a main-chain i + 4 → i (Ni+4–H···O=Ci–Ni+1) H-bond and contains nine sp2 atoms and three complete residues. We present the term “1393 structures” to denote them. Early HBS models1,52,60 were 1382 structures, containing two complete residues and eight sp2 hybridized atoms in the HBS-constrained 13-membered rings, and have been excellent for nucleating α-helices56,6167 in longer (>7 residues) sequences. However, the i + 1st residue is replaced by an ethyl group in these HBS models and only the i + 2nd and i + 3rd residues are retained in the HBS-constrained ring. Due to lack of molecular recognition from both the Cα-stereochemistry of the i + 1st residue and its side-chain functional group, these HBS models cannot efficiently mimic single α-helical turns. Later, HBS models that retained all three residues in the HBS-constrained 13-membered ring were introduced.57,58,68 These contained six sp2 hybridized atoms (termed 1363 structures) and constrained short (≤6 amino acid) peptides with moderate conformational homogeneity and modest α-helicities (typical circular dichroism (CD) θn→π*MRE values of <−15 × 103 deg cm2 dmol–1), compared to the helicities observed in infinite α-helix models69 (whose CD θn→π*MRE values are ∼−43 × 103 deg cm2 dmol–1). Hence, more efficient HBS models are needed to bias shorter (four amino acid) peptides predominantly into single α-helical turns.

Figure 1.

Figure 1

ChemDraw diagrams of the (a) i + 4 → i H-bonded natural single α-helical-turn 13-membered ring, containing nine sp2 atoms and three complete residues (1393). (b) Current HBS-constrained 1373 models constrained in single α-helical turns, containing all three residues. Preferences for Gly and Ala residues at the i + 1st, i + 3rd, and i + 4th positions have been determined. (c) Earlier HBS-constrained 1382, 1362 models, lacking the i + 1st residue. The sp2 atoms are numbered in each model.

We hypothesized that once an HBS that retains all three residues is in place, increasing the number of sp2 hybridized atoms (from six to seven) in the HBS model can reduce ring flexibility and lead preferably to adopt majorly the α-helix. We thus designed the 1373 structures, containing all three residues and 7 sp2 atoms in the HBS-constrained 13-membered macrocycle. To this end, (i) we replace the labile Ni+4–H···O=Ci–Ni+1 motif in various tetrapeptides by the covalent 1,3-propanediamine surrogate (Ni+4–CH2–CH2–CH2–Ni+1) and (ii) introduce the Ni+1-methyl-oxycarbonyl (Ni+1–Moc) group (Figures 1 and 2c). The Ni+1–Moc derivatization introduces the seventh sp2 atom. CD, Fourier transform infrared (FT-IR) absorption, one-dimensional (1D)-NMR, two-dimensional (2D)-NMR spectral and computational analyses show that these 1373 analogues have a propensity to adopt remarkably stable α-helical conformations in varying solvents, pH values, and temperatures, unlike their corresponding 1363 models (without the Ni+1–Moc group), which are disordered.

Figure 2.

Figure 2

Comparative (θ × 103 deg cm2 dmol–1 vs λ nm) plots of (a) 1ac and (b) 1a, 1d, and 1e in acetonitrile (100 μM, 295 K). (c) Labeled stick diagram of the current 1373 HBS model. (d) Residue preferences for each unnatural position in the HBS-constrained α-helical turns.

We also note that any HBS constraint introduces unnatural environments at i + 1st, i + 3rd, and i + 4th positions. Our current 1373 HBS model, for example, introduces a tertiary carbamate at the N-terminus of the i + 1st residue and a tertiary amide between the i + 3rd and i + 4th residues. As a result, the residue preferences at each of these unnatural positions need not be the same as they are in a natural α-helix, where alanine (Ala) has the highest helix propensity and glycine (Gly) has the lowest (excluding proline).15,16,70 Determining residue preferences at these positions in the current HBS environment is essential for designing single-turn α-helices with high, predictable helicities, for various chemical biological applications. Hence, we synthesize 1373 analogues with Gly and Ala variations at these positions. Here, Ala is representative of the stereochemical environment at Cα of all non-Gly residues (excluding proline). By comparing the α-helicities of these 1373 analogues with those of the corresponding 1363 analogues and acyclic tetrapeptides, we determine the optimum sequences that render single α-helical turns with the highest α-helicities (θn→π*MRE ∼−25.3 × 103 deg cm2 dmol–1) reported thus far. Based on 2D-NMR and CD data, reasons for consistent differences between α-helicities of highly stable HBS-constrained single-turn α-helices and the natural infinite helix models are also explored. Our results reveal the criteria for achieving maximum helicity and have immediate applications for designing mimetics of biologically important single α-helical turns, which form the crucial recognition element in several protein–protein interactions.8,9,18

Results and Discussion

The list of 1373 and 1363 macrocyclic analogues and their corresponding acyclic tetrapeptides (1ae, 2ac, and 3ac, respectively), synthesized following our earlier reported solution phase protocol for accessing short 310-helical mimics,71 are tabulated in Table 1. Residues in parenthesis are entirely contained within the 13-membered ring, constrained by the current HBS model. Phe was chosen at the invariable i + 2nd position for easy visualization of the molecules on thin-layer chromatography (TLC) and hence their facile purification. The AGADIR72 predictor showed <0.4% helicities (Table S6, Supporting Information (SI)) for all of the chosen sequences.

Table 1. List of HBS-Constrained 1373 and 1363 Analogues and Corresponding Acyclic Peptides Synthesizeda.

HBS-constrained cyclic peptidomimetics
   
cpd. 1373 cpd. 1363 cpd. linear peptide analogues
1a X-[G1F2A3]G4-OMe 2a H-[G1F2A3]G4-OMe 3a Y-G1F2A3G4-OMe
1b X-[A1F2A3]G4-OMe 2b H-[A1F2A3]G4-OMe 3b Y-A1F2A3G4-OMe
1c X-[G1F2A3]A4-OMe 2c H-[G1F2A3]A4-OMe 3c Y-G1F2A3A4-OMe
1d X-[G1F2G3]G4-OMe  
1e X-[A1F2G3]G4-OMe
a

X, methyloxycarbonyl; Y, tert-butyloxycarbonyl.

The far-UV CD spectra of 1ae, 2ac, and 3ac were recorded first in the apolar solvent CH3CN in which backbone conformations and excitonic transitions will be weakly perturbed by solvent H-bonding interactions (HBIs), unlike in water. Concentration-dependent CD spectral analyses (60–500 μM, Figures S24, S27, and S30, SI) revealed nonvariance of the spectral shape and mean residue ellipticities for the n → π* transitions (θn→π*MRE, which occurs around 227 ± 1 nm), indicating the nonassociative nature of these analogues (Figure 3).

Figure 3.

Figure 3

Comparative CD (θ × 103 deg cm2 dmol–1 vs λ nm) plots (CH3CN, 100 μM, 295 K) of HBS-constrained 1373 (1ac) and 1363 (2ac) analogues, along with those of their corresponding acyclic (3ac) tetrapeptides. The tetrapeptide sequences are (a) GFAG, (b) AFAG, and (c) GFAA, respectively.

Excitonic coupling10 between electronic transitions of peptide chromophores yields trisignate CD patterns (positive maximum at ∼194 nm for the π → π*parallel transition and negative maxima at ∼208 and ∼222 nm for the π → π*perpendicular and n → π* transitions), only in analogues where the electric dipole transitions of the peptides have an absolute helical orientation between themselves.2,10 Among the 1373 analogues (1ae), (Figure 2a) the α-helical triple band is clearly seen in 1ac. The θn→π*MRE and θπ→π*MRE magnitudes are the highest in 1a and are comparable to those observed in well-known single α-helical turn models73,74 constrained by side-chain–side-chain covalent linkers, which were studied in water. This indicates a high α-helix content in 1a despite the lack of H-bonding interactions (HBIs) for the peptide chromophores, with either the solvent or any extended helical sequence. All three θn→π*MRE and θπ→π*MRE intensities in the Glyi+1 → Alai+1 analogue 1b are diminished (∼62% of 1a), indicating the weakening in delocalization of the excitonic energy over the three interacting peptide chromophores, which alludes to the perturbation of at least one of the peptide planes away from α-helical organization (compared to 1a). This is expected due to the increased steric strain in 1b, where all three HBS-constrained residues are Cα substituted (unlike in 1a). In 1c, the Glyi+4 → Alai+4 analogue of 1a, the θn→π*MRE and θπ→π*MRE intensities are low and the n → π* band is broadened up to ∼218 nm.10,27 The CD of 1d, the Ai+3 → Gi+3 analogue of 1a, reveals the absence of selective preference for right- or left-handed structures. The shallow positive maximum at ∼199 nm and negative maxima at ∼218 and ∼229 nm in 1e, the analogue with Gly next to all of the tertiary carbamates, revealed a mixture of non-α-helical-turn structures28 (Figure 2b). Thus, in the backdrop of the 1373 constraint, the residue Cα-stereochemistries further influence the α-helicity (the extent to which the constrained α-helical fold mimics a natural α-helical fold) and Gly is the most preferred residue at i + 1st and i + 4th positions, unlike in natural α-helices (Figure 2d).

For reliable correlation of CD spectral features of the constrained homologues with changes in their relative chromophoric arrangements, their conformations need to be stable. The CD patterns and θn→π*MRE values (CH3CN) of 1ac (the analogues with positive maximum helical structures) remain remarkably unchanged with the increase in temperature.75 The thermal ellipticity coefficient (Δθ/ΔK, change in θ per degree change in temperature, the slope of the linear fit of θn→π*MRE vs T) of 1a (Figure 4a) is comparable to that of the most stable natural single-helical-turn peptide model reported by Baldwin et al.69 Δθ/ΔK of 1b is closer to zero (closest reported yet) (Table S7, SI), consistent with rigidification of the macrocycle due to steric crowding. The helices also do not unfold with the increase in pH (Figure 4c) or concentration of urea (Figure 4b), the latter of which is known to solvate the peptide groups better than water and hence otherwise cause unfolding.26 These indicate nonperturbation of interpeptide orientations, owing to which the influence of exciton–solvent interactions on CD patterns of the homologues is clearly discernible in current helical models.

Figure 4.

Figure 4

Variance of θn→π*MRE in 1a and 1b with (a) temperature (CH3CN) and (b) concentration of urea (H2O) and in 1ac with (c) pH (30 mM buffers). The thermal ellipticity coefficients (Δθ/ΔK) for 1a and 1b (CH3CN) are presented in (a). In all cases, the peptide concentration is 100 μM.

The helix diagnostic triple bands of 1ac are retained in water (Figure 5a–c), as in CH3CN, with the n → π* bands blue-shifting and the π → π* bands red-shifting, consistent with similar observations in uncoupled, isolated peptides.2931 Remarkably though, the magnitudes of these helically coupled θn→π*MRE and θπ→π*MRE are enhanced by ∼1.6–2.0-fold (Table S8, SI) in water, compared to CH3CN. The θn→π*MRE values are similar in the hydroxy solvents trifluoroethanol (TFE) and water (each of which have different dipoles but comparable strengths of H-bonds76) but are slightly enhanced further in pH 7 buffer (Figure 5d), where the peptides additionally interact with ionic phosphates, with 1a showing one of the highest known values for a single α-helical-turn model33,68,69,73,77,78 (Table S7, SI). The CD pattern and hence θn→π*MRE remain relatively unperturbed by significant (×107-fold) variations in [H+] (Figure 5c). The extents of such enhancements are typically lower in the corresponding acyclic analogues 3ac (Table S9, SI), where the transitions are randomly coupled. These results reveal that solvent interactions perturb both the excitonic transition energies and their delocalization, when the chromophores are chirally organized even in a single α-helical turn; in addition, the magnitudes of such perturbations are strongly influenced by solvent–chromophore H-bonding and ionic interactions (than by protonation) of the coupled chromophores. An important outcome of these results is that the reference ellipticities for infinite α-helix models should have solvent-dependent (and not universal singular) values.

Figure 5.

Figure 5

Solvent-dependent CD spectra of (a) 1a, (b) 1b, and (c) 1c (100 μM) in CH3CN, TFE, water, and pH 7 (30 mM phosphate) buffer; (d) variance of θn→π*MRE of 1ac with different solvents (gray, CH3CN; black, TFE; red, water; blue, pH 7).

CD spectra of the corresponding 1363 analogues 2ac (Ni+1 is sp3 hybridized) lacked any notable CD bands (Figure 3a–c), consistent with earlier observations of conformational heterogeneity even in the Ni+1-sulfonamide derivatives of such analogues.57 This reveals that merely linking Ni+4 and Ni+1 of tetrapeptides in H-bonding proximity is insufficient for biasing of their backbone predominantly into single α-helical-turn conformations. But once they are constrained, the number of sp2 atoms in the macrocycle strongly influences largely α-helical conformation, with the threshold number being 7, as in the 1373 structures 1ac. Lack of helicity even in 2b shows that it is not sufficient that all residues in the HBS-constrained macrocyle are Cα-trisubstituted (non-Gly). Both the number of sp2 atoms and residue preferences are complementary and are important for high α-helicities of HBS models. This explains the loss in helicity observed in earlier HBS helix models upon reduction of the ethylene HBS1 to ethane HBS.63,79 The acyclic analogues 3ac showed random-coil CD patterns (Figure 3a–c) as predicted by AGADIR,72 highlighting the propensity of the current HBS model to orient unstructured tetrapeptides primarily into single α-helical turns.

FT-IR spectra (CH3CN, 2 mM) showed amide I ṼC=O bands between 1654 and 1657 cm–1 for both the 1373 analogues 1a and 1b (Figure 6), consistent with the predominance of α-helical-turn organization between the peptides.22,37 To elucidate the structural stability and to further confirm the presence of α-helical conformation, the FT-IR spectra of N-deuterated 1a and 1b were recorded, which also yielded the amide I bands at 1656 and 1657 cm–1, respectively. Absence of significant shifts in the C=O stretch bands indicated the nonexchange of the single α-helical turn in 1a and 1b to nonhelical conformations.80 The 1639 cm–1 band for 1c revealed predominance of β-turn structures (C′i+1–Ci+2α–Ci+3α–Ni+4 torsion angle = 31.0°, which are descriptors of β-turns).8184

Figure 6.

Figure 6

Comparison of amide I ṼC=O regions (CH3CN, 2 mM, 295 K) in the FT-IR spectra of 1373 analogues, 1c–a (a–c); their deuterated amide (N–D) analogues (d) 1b (D) and (e) 1a (D), and their respective 1363 analogues (H2O, 2 mM, 295 K) 2ca (f–h).

FT-IR spectra (H2O, 2 mM) of the corresponding 1363 analogues 2ac showed an amide I band ṼC=O at 1637 cm–1, indicating a heterogeneous mixture of random-coil conformations in them (Figure 6f–h). This is consistent with the CD data indicating that the predominance of the single α-helical turn is induced in random-coil turns upon introduction of the seventh sp2 atom in the 13-membered rings. Note that the 1363 analogues being ammonium salts were insoluble in organic solvents but were generally soluble in H2O. Such a comparison of amide I bands in different solvents for the 1373 and 1363 analogues is agreeable since the FT-IR C=O stretching frequencies in α-helical and random-coil conformations are little perturbed by changes in solvent polarities8587 (Table S10, SI). As expected, the acyclic analogues 3ac showed similar random-coil values for the amide I ṼC=O (1636–1639 cm–1), confirming the role of the current HBS model in inducing α-helicity in unstructured tetrapeptide sequences.

1H NMR (CDCl3/CD3CN 2:3) spectra of the 1373 analogues showed three sets of spin systems in 1a and two sets in 1b and 1c of which one predominated, in each. From 2D total correlation spectroscopy (TOCSY), 13C–1H heteronuclear single quantum coherence (HSQC) and 1H–1H rotating frame Overhauser effect spectroscopy (ROESY) spectral correlations (Figure 7a–c), and the relative intensities of the signal sets (see SI), the major/minor ratios were determined to be 77:15:8 (1a), 74:26 (1b), and 89:11 (1c). The presence of ROESY exchange peaks between protons of the major and minor species indicated that they are conformational isomers (Figures S7 and S20, SI).

Figure 7.

Figure 7

ChemDraw diagrams of the crucial ROE cross-peaks in the major conformers of (a) 1a (77%), (b) 1b (74%), and (c) 1c (89%) and the stick and ribbon representations of their corresponding energy-minimum structures, in (d)–(f) showing only the Hs exhibiting ROEs. The phenyl group of Phei+2 is removed for clarity. The rise (Å) in the helical turn is denoted by Ci+1α···Ci+4α distance.

The structures of the major conformers of 1ac (Figure 7d–f) were calculated using their ROE distance restraints. The ROEs were classified as strong, medium, and weak, and their distance boundaries were assigned (Table S11, SI). The initial random structure was optimized in Automatic Topology Builder (ATB)39 using the semiempirical quantum mechanics (QM) theory,40 followed by energy minimization using the GROMOS 54A7 force field41 in a box of pre-equilibrated simple point charge (SPC) water molecules. In 1a and 1b, the HBS-constrained tripeptide backbones make a right-handed turn, with the propyl group supporting α-helical rise (from Ci+1α to C′i+4), of 5.1 and 5.2 Å, respectively, comparable to those in ideal natural α-helices (5.4 Å). In 1c, the backbone twists away from a right-handed turn at residues i + 3 and i + 4. The N–Moc carbamate plane is similarly obtusely inclined from the propagating helix axis in 1ac to avoid 1,2 strain between the Moc group and Ci+1α substituents. This results in an upflip of the sp2 hybridized Ni+1 and hence an unnatural positive value for φi+1, a common feature in these analogues (Table 2). The rest of the backbone φ, ψ dihedral angles are negative in 1ac and consistent with those in the classical α-helical turn43,44,88,89 (with 1a showing the least root-mean-square deviation (RMSD), Table 2 and Figure 8) and with the crystal structure of the olefin HBS model.59 The s-cis and s-trans rotamers of the methyl carbamate group at the Ni+1 nitrogen are energetically indistinguishable. There are no ROE cross-peaks for the methyl group of methyl carbamate either, indicating that the carbamate group is remotely disposed from the α-helical turn. Hence, Ni+1 nitrogen has the potential to anchor various carbamates and acyl groups without affecting the 1373 HBS-constrained α-helical-turn conformations.

Table 2. List of (φ, ψ) Backbone Dihedral Angles and Backbone RMSD between Helical Folds in 1ac and Their Natural Sequences.

helix models (Φ, ψ)i+1 (Φ, ψ)i+2 (Φ, ψ)i+3 (Φ, ψ)i+4 RMSD (Å)
α-helixa –65, −40 –65, −40 –65, −40   0
[xQV]Ab   113, −46 –71, −47 –55, −45  
1a 83, −122 –88, −39 –72, −49 –75, −42 0.41
1b 47, −99 –102, −5 –107, −54 –78, −34 0.64
1c 65, −93 –87, −26 –92, −2 63, 36 1.27
a

Flanagan et al.44

b

Arora et al.59

Figure 8.

Figure 8

C′i=Oi···C′i+1=Oi+1 dihedral angles representing interchromophore orientations and the C′i···C′i+1 distances are tabulated for 1ac. Backbone superimposition of the GROMOS energy-minimized 1ac (in green), with their corresponding natural α-helices (built with Discovery Studio) (in GBR)(top view).

The folds in 1a and 1b are similar, while that in 1c is significantly different, substantiated by comparable 1H and 13C NMR chemical shifts (Figure 9 and Table S4) for 1a and 1b and not 1a and 1c. In both 1a and 1b, the crucial exocyclic φi+4 torsion is negative, as in a propagating helix. This is imperative for application of these HBS models for probable propagation of α-helicity in sequences appended at their C-terminal. However, in 1c, it is positive as in a nonpropagating turn and results in an oblique twist of the i + 3–i + 4 peptide plane. Imposition of negative values for φi+4 in computational models of 1c resulted in multiple unavoidable intramolecular van der Waals steric clashes involving CβH3 of Alai+4, indicating that propagation is probable at Glyi+4 but is precluded by Alai+4.

Figure 9.

Figure 9

Tables of (a) 13C and (b) 1H, chemical shifts (ppm) of 1ac (CDCl3/CD3CN, 2:3), 5 mM, 295 K. Atomwise bar plots of corresponding Δδ ppm (δ1a–δ1b and δ1a–δ1c) values from (c) 13C and (d) 1H NMR spectra.

The unnatural i + 3–i + 4 tertiary amide bond adopts the s-trans rotamer in all analogues, and the s-cis rotamer is sterically disallowed. In the cis rotamer, the C=O has to flip inward of the macrocycle. This is made impossible because the Cα-substituents of both i + 3rd and i + 4th residues infringe severely into each other’s hard-sphere van der Waals space in this rotamer. Alternatively, in the cis rotamer, the i + 4th residue backbone has to flip inward, which is all the more impossible. Note that the s-cis rotamer is reported to be disallowed even in the 1363 analogues, with a lesser ring strain.57,58

The ROE-consistent GROMACS-derived minor conformers of 1a and 1b are due to the flipping of the i + 3–i + 4 peptide plane away from the helix axis, which makes it almost perpendicular to the other two peptide planes (Figure 10). This conformer is a kinetic minimum. 1a, which contains two highly flexible Gly residues (at i + 1st and i + 4th positions), shows an additional such (third) conformer (8%) in 1H NMR, whose structure we are unable to characterize due to its low relative population and hence the lack of any corresponding spectral signals, especially in the 2D-NMR. It can at best be speculated that the third rotamer (and the minor conformer of 1c) is one of the kinetic minima like those reported by Broussy et al.,57,58 where there is flipping of one or more of the peptide planes.

Figure 10.

Figure 10

Energy-minimized structures of minor conformers of (a) 1a and (b) 1b. (c) The list of (Φ, ψ) values from the energy-minimized structure of the minor conformers.

Interchromophore orientations90 (Figure 11a) (defined by C′i=Oi···C′i+1=Oi+1 dihedral angle, C′i···C′i+1 distance, Oi···C′i+n distance, Oi···C′i+n=Oi+n angle, and C′i=Oi···C′i+n=Oi+n torsion, n = 1, 2; Table S12, SI) strongly influence CD patterns and hence are good markers for comparative analyses of NMR and CD data. Comparison of these parameters in 1ac (Figure 11b–d) with those in the natural classical α-helical turn containing the corresponding sequences (built in Discovery Studio) revealed that for 1a the interpeptide torsions and angles are nearly comparable, consistent with its remarkably high CD θn→π*MRE values. However, the interpeptide separation increases by ∼0.6–0.7 Å more than in the natural α-helix, which is expected since the HBS motif occupies a larger volume compared to the natural H-bond that it replaces in the helix. Since excitonic couplings decrease by the inverse cube of the interchromophore distance,34 this explains why θn→π*MRE for 1a is not the same as that for natural infinite α-helix models69 (∼−43 × 103 deg cm2 dmol–1) but is lower. Similarly, increased distances are expected in most HBS-constrained single-turn α-helix models, which explains their consistently lower θn→π*MRE values than natural α-helices. Considering the structural similarity between 1a and the natural α-helix, we present its θn→π*MRE (∼−25.3 × 103 deg cm2 dmol–1 at pH 7) from current studies to be representative of the infinite α-helicity values for HBS-constrained single α-helical turns. The value decreases in weakly H-bonding solvents. In 1b, the intercarbonyl (C=Oi···C=Oi+1) dihedral angles are distorted for the i + 1 → i + 2 peptide pair (Figure 8). Their peptide separations are comparable, too, but still greater than those in 1a. Both interpeptide orientations and separations thus influence their decreased helicities. In 1c, the distances and orientations of both peptide pairs are significantly perturbed from canonical values, leading to poor helicities. Thanks to the rigidity enforced in these HBS-constrained structures, the influence of such subtle differences in interpeptide orientations due to variations in sequence, on CD bands, is clearly observable.

Figure 11.

Figure 11

(a) ChemDraw representation of interchromophoric orientation. Comparison of intercarbonyl (b) torsion (C′=O···C′=O), (c) angle (O···C′=O), and (d) distance (O···C′) between HBS-constrained peptides in 1a (black), 1b (red), and 1c (blue) with those in the classical α-helix (empty) built from corresponding sequences with Discovery Studio.

Note that unlike the N–Moc-protected 1373 analogues 1ac (which are soluble in 40% CDCl3 in a CD3CN solvent mixture), their corresponding 1363 analogues 2ac are ammonium salts and are generally soluble in water, in which their NMR spectra are recorded (Table S5, SI). Due to the difference in solvent conditions, the NMR chemical shifts91 and 3J Hz scalar coupling values9294 of 1ac and 2ac are not comparable (Figure S23, SI). However, the conformational states of 1363 analogues similar to 2ac have been extensively analyzed earlier57 and were found to contain up to 10 different conformers, with no predominance of any ordered structures in the mixture. This is consistent with CD and FT-IR data of the current 1363 analogues, 2ac. The predominance of α-helical conformations in the 1373 analogues 1ac, on the other hand, based on their 1H, 13C, 2D-NMR data, and molecular dynamics simulation analyses, thus further confirms that a threshold number of seven sp2 atoms is essential for such conformational predominance in HBS-constrained peptidomimetics.

Conclusions

A covalent H-bond surrogate (HBS) model is presented for constraining unordered tetrapeptides in 13-membered-ring single-α-helical-turn conformations with high stability under varying conditions of temperatures, solvents, and pH values. In this HBS model, the n-propyl group replaces the i + 4 → i H-bond and the N–Moc group sp2 hybridizes the Ni+1 atom. In the backdrop of the HBS-constrained 13-membered rings, strong influence of the number of sp2 atoms is observed as to obtain predominantly single α-helical-turn conformation. Seven sp2 atoms are essential, with six yielding heterogeneous structures. Residue preferences at the unnatural i + 1st, i + 3rd, and i + 4th positions of the HBS helix were determined by systematic CD, FT-IR absorption, 1D-, 2D-NMR spectral and computational analyses of Gly/Ala mutants at these positions, for their predictable application. Unlike in natural α-helices, Gly can be accommodated in these HBS helices and, when placed at the i + 1st position, yield the highest known helicities for single α-helical-turn models. Alai+1 rigidifies the helical turn and yields slightly reduced α-helicities than Glyi+1. Alai+3 (non-Glyi+3) is necessary, as Glyi+3 yields a mixture of turns. Glyi+4 is essential for probability of propagation downstream from the constrained α-helix. Alai+4 precludes such propagation and twists the i + 3–i + 4 tertiary amide bond away from the helix axis. The θn→π*MRE value (∼−25.3 × 103 deg cm2 dmol–1 at pH 7) for 1a (Moc[GFA]G-OMe), the analogue containing the most preferred residues in all positions, is presented as a reference for ideal single-turn α-helices with the HBS constraint. The primary reason for the difference between this value and that of natural infinite α-helices is found to be the unavoidable greater interpeptide distance, due to the presence of the large HBS motif in the former. Current results facilitate chemical and biological investigations by providing crucial design criteria for predictable access to HBS-constrained stable single-turn α-helices. By setting a paradigm for an ideal α-helical turn with the highest helicity, our findings propose a strategy for increasing the helicity of mimetics of biologically important single α-helical turns and thus optimizing their relevant functionality.

Experimental Section

General Details

The protected amino acids were purchased from G.L. Biochem Ltd., China, and were used without additional purification. All reactions were carried out in oven-dried round-bottom flasks. Flash chromatography was performed on silica gel standard grade (100–200 mesh) for purification of all of the intermediate compounds. Nuclear magnetic resonance (NMR) spectra of compounds were recorded on a Bruker-AV400 spectrometer (Bruker Co., Faellanden, Switzerland). 1H NMR spectra were recorded in CDCl3 or 40% CDCl3/CD3CN or 10% D2O/H2O on a Bruker 400 MHz (100 MHz for 13C) spectrometer. Chemical shifts were reported relative to tetramethylsilane (TMS) (δ 0.00 ppm) for 1H NMR and 13C NMR, respectively. High-resolution mass spectra (HRMS) were recorded on a Xevo TQ-XC mass spectrometer (Water, Massachusetts). Multiplicities are indicated using the following abbreviations: s (singlet), d (doublet), dd (doublet of doublets), dt (doublet of triplet), t (triplet), q (quartet), quin (quintet), sext (sextet), hept (heptet), m (multiplet), and bs (broad singlet).

CD Spectroscopic Analyses

CD spectra were recorded in the far-UV range, from 185 to 270 nm, at 295 K with a scan speed of 50 nm min–1 and with each reading averaged over three scans. Spectral baselines were obtained under conditions analogous to those for the samples. The blank solvent spectra for each solution were recorded under the same conditions. Solutions were prepared by weighing out the peptide in a volumetric flask and adding the solvent for dilution up to the marks, ensuring the dissolving of the peptide, followed by filtering of the solution through a 0.2 μm polyvinylidene difluoride (PVDF) membrane filter (Pall India Pvt. Ltd., Mumbai). All of the spectra were baseline-corrected, and θ values were recorded in mdeg units. Each data point was then converted to uniform-scale molar ellipticity θ (deg cm2 dmol–1) values. The corresponding mean molar residue ellipticity (θMRE) values were then calculated by the equation θ/n (where n is the number of peptide bonds in the peptide), and the θMRE (deg cm2 dmol–1) values were plotted as a function of corresponding λnm. Temperature-dependent CD experiments were performed by varying the temperature of the samples using the JASCO Peltier instrument, allowing 15 min of equilibration time at each temperature before recording each data point.

FT-IR Spectroscopic Analyses

IR spectra were recorded using a Bruker spectrophotometer. A cell with path length 0.1 cm (with KCl window) was used for the solution measurements. All of the spectra were baseline-corrected with respect to the blank solvent (spectrograde CH3CN purchased from Merck) with a minimum of 16 scans being signal-averaged. For acquiring the FT-IR for the deuterated analogues of 1a and 1b, the peptides were dissolved (5 mM concentration) in 100% CD3OD (99.8% deuterated) and kept standing for 1 h and 1H NMR were taken to ensure the complete exchange of NHs to NDs. Then, CD3OD was removed under reduced pressure until complete dryness. Further, the peptides were redissolved in CH3CN (2 mM concentration) and the spectra were recorded.

Procedure for Energy Minimization

Energy minimization was carried out on all three 1373 analogues 1ac, starting from the structure that is built based on the 2D ROESY constraints. The interproton distances are taken care of based on the ROE intensities. The molecule was then uploaded into the ATB topology builder to generate the initial optimized geometry using the semiempirical QM theory (SCF level of theory) and MOPAC charges. Bonded and van der Waals parameters were taken from the GROMOS 54A7 parameter set. All three molecules were then placed in a suitable cubic box with the box edge adjusted to 1 Å from the peptide’s periphery. The box was filled with a suitable number of pre-equilibrated SPC water molecules. Then, energy minimization was done using the steep (steepest descent minimization) algorithm for all three molecules, which were restrained to their initial coordinates with a force constant of 100 kJ mol–1.

General Procedure for the Cyclization Reaction

(Scheme S24, SI) MeOH (3.0 mL) was added to a mixture of 10a (300 mg, 0.43 mmol) and Pd–C (0.1 mol %) in a sealed round-bottom flask kept under a H2 atmosphere and stirred for 20 min by which time TLC indicated complete consumption of the starting material. Filtering the mixture through Whatman-40 filter paper and concentration of the organic filtrate gave the N- and C-terminal double deprotected derivative of 10a as a viscous liquid 11a (208.8 mg, 0.43 mmol). Next, 11a was dissolved in dry CH3CN (1.0 mM) (420.0 mL) followed by addition of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) (410.6 mg, 2.15 mmol), hydroxybenzotriazole (HOBT) (174.1 mg, 1.29 mmol), and N,N-diisopropylethylamine (DIPEA) (375.0 μL, 2.15 mmol) under a N2 atmosphere. The mixture was stirred for a further 7 h. Removal of the solvent resulted in a residue that was dissolved in dichloromethane (DCM) (30.0 mL) and washed with water (2 × 15.0 mL), 1 N HCl (2 × 15.0 mL), and saturated NaHCO3 (2 × 15.0 mL). The organic layer was dried over anhyd. Na2SO4 and concentrated to get a residue, which was subjected to purification by silica gel flash column chromatography.

Methyl (5S,8S)-5-Benzyl-10-(2-methoxy-2-oxoethyl)-8-methyl-3,6,9-trioxo-1,4,7,10-tetraazacyclotridecane-1-carboxylatewhite (1a)

White solid (89.35 mg, 0.19 mmol, 46% yield); (TLC—EtOAc/methanol (9:1)—Rf = 0.7); 1H NMR (400 MHz, 40% CDCl3 in CD3CN, 5 mM) δ ppm: major conformation: 7.33–7.21 (m, 5H, HAroPhe), 6.61 (d, J = 9.29 Hz, 2H, HNPhe + Ala), 4.75 (dt, J = 16.57, 10.07 Hz, 1H, HαAla3), 4.50 (d, J = 15.11 Hz, 1H, HαGly1), 4.44 (d, J = 19.05 Hz, 1H, HαGly4), 4.31 (q, J = 6.12 Hz, 1H, HαPhe2), 4.11 (t, J = 13.52 Hz, 1H, Hprpc), 3.77 (d, J = 19.12 Hz, 1H, HαGly4), 3.71 (s, 3H, HMeOMe), 3.66 (d, J = 9.27 Hz, 1H, HMeMoc), 3.54 (d, J = 16.17 Hz, 1H, HαGly1), 3.45–3.32 (m, 1H, Hprpa), 3.30–3.16 (m, 1H, Hprpa), 3.04–2.96 (m, 2H, HβPhe2), 2.52 (d, J = 14.53 Hz, 1H, Hprpc), 2.29–2.17 (m, 1H, Hprpb), 1.87–1.74 (m, 1H, Hprpb), 1.33 (d, J = 6.11 Hz, 1H, HβAla3), 1.21 (d, J = 6.37 Hz, 3H, HβAla3); minor conformation: 7.17–7.09 (m, 0.11H, HNPhe2), 7.07–6.98 (m, 0.19H, HNPhe2), 6.91–6.83 (m, 0.11H, HNAla3), 6.76–6.67 (m, 0.19H, HNAla3); 13C NMR (100 MHz, 40% CDCl3 in CD3CN, 5 mM) δ ppm: (mixtures of major and minor conformers) 173.2, 171.5, 170.9, 170.1, 136.7, 129.7, 129.1, 127.6, 58.1 (CαPhe2), 52.9 (CMeMoc), 52.6 (CMeOMe), 52.5 (CαGly1), 48.2 (CαGly2), 46.0 (Cprpa), 44.4 (CαAla3), 42.9 (Cprpc), 36.8 (CβPhe2), 16.9 (CβAla3); FT-IR ( cm–1) (CH3CN, 2 mM): 2978, 2868, 1749, 1700, 1657, 1528, 1472, 1358, 1315, 1290, 1220; HRMS m/z calcd for C22H30N4O7Na 485.2012, found 485.2014.

Methyl (5S,8S)-5-Benzyl-10-(2-methoxy-2-oxoethyl)-2,8-dimethyl-3,6,9-trioxo-1,4,7,10-tetraazacyclotridecane-1-carboxylate (1b)

White solid (77.6 mg, 0.16 mmol, 38% yield); (TLC—EtOAc/methanol (9:1)—Rf = 0.8); 1H NMR (400 MHz, 40% CDCl3 in CD3CN, 5 mM) δ ppm: major conformation: 7.36–7.20 (m, 5H, HAroPhe2), 6.68 (d, J = 9.86 Hz, 1H, HNAla3), 6.51 (s, 1H, HNPhe2), 4.78 (dt, J = 17.02, 6.70 Hz, 1H, HαAla3), 4.69–4.62 (m, 1H, HαAla1), 4.58 (d, J = 19.13 Hz, 1H, HαGly4), 4.25–4.17 (m, 1H, HαPhe2), 4.1 (t, J = 13.63 Hz, 1H), 3.76 (d, J = 18.99 Hz, 1H, HαGly4), 3.71 (s, 3H, HMeOMe), 3.29–3.19 (m, 1H, Hprpa), 3.21–3.17 (m, 1H, Hprpa), 3.07–2.97 (m, 2H, HβPhe2), 1.76–1.66 (m, 1H, Hprpb), 1.28 (d, J = 7.07 Hz, 3H, HβAla1), 1.24 (d, J = 6.27 Hz, 3H, HβAla3); minor conformation: 7.17–7.12 (m, 0.36H, HNPhe2), 7.12–7.07 (m, 0.36H, HNAla3); 13C NMR (100 MHz, 40% CDCl3 in CD3CN, 5 mM) δ ppm: (mixtures of major and minor conformers) 174.3, 172.0, 171.8, 171.7, 170.9, 138.3, 137.6, 130.6, 130.5, 130.3, 130.9, 129.8, 129.7, 128.4, 128.2, 59.2 (CαPhe2), 58.3 (CαAla1), 53.5 (CMeMoc), 53.4 (CMeOMe), 48.9 (CαGly4), 45.0 (CαAla3), 43.5 (Cprpc), 41.4 (Cprpa), 37.6 (CβPhe2), 28.9 (Cprpb), 17.4 (CβAla1), 15.9 (CβAla3); FT-IR ( cm–1) (CH3CN, 2 mM): 2992, 2946, 1750, 1691, 1654, 1527, 1507, 1472, 1440, 1402, 1375, 1302, 1210, 1112, 1059, 1003; HRMS m/z calcd for C23H32N4O7Na 499.2169, found 499.2166.

Methyl (5S,8S)-5-Benzyl-10-(1-methoxy-1-oxopropan-2-yl)-8-methyl-3,6,9-trioxo-1,4,7,10-tetraazacyclotridecane-1-carboxylate (1c)

White solid (45 mg, 0.09 mmol, 22% yield); (TLC—EtOAc/methanol (9:1)—Rf = 0.8); 1H NMR (400 MHz, 40% CDCl3 in CD3CN, 5 mM) δ ppm: major conformation: 7.14 (d, J = 8.49 Hz, 1H, HNPhe2), 7.35–7.23 (m, 5H, HAroPhe), 7.16 (d, J = 9.49 Hz, 1H, HNAla3), 4.76 (q, J = 6.72 Hz, 1H, HαAla3), 4.65 (q, J = 7.90 Hz, 1H, HαPhe2), 3.99 (d, J = 13.44 Hz, 1H, HαGly1), 3.86 (q, J = 6.88 Hz, HαAla4), 3.74 (s, 3H, HMeOMe), 3.70–3.67 (m, 1H, HαGly1), 3.62 (s, 3H, HMeMoc), 3.38–3.28 (m, 1H, Hprpc), 3.27–3.18 (m, 1H, Hprpa), 3.13–3.04 (m, 1H, HβPhe2), 3.03–2.97 (m, 1H, Hprpc), 2.97–2.91 (m, 1H, HβPhe2), 1.91–1.79 (m, 1H, Hprpb), 1.72–1.60 (m, 1H, Hprpb), 1.40 (d, J = 6.58 Hz, 3H, HβAla4), 0.94 (d, J = 6.49 Hz, 3H, HβAla3); minor conformation: 6.99–6.91 (m, HNAla3), 6.84–6.74 (m, HNAla3); 13C NMR (100 MHz, 40% CDCl3 in CD3CN, 5 mM) δ ppm: (mixtures of major and minor conformers) 173.3, 172.0, 171.4, 171.3, 158.6, 138.3, 130.54, 130.48, 129.9, 129.7, 128.2, 128.0, 57.6 (CαAla4), 57.4, 56.0 (CαPhe2), 54.3 (CαGly1 + CMeOMe), 53.0 (CMeMoc), 48.1 (Cprpc), 47.5 (Cprpa), 46.9 (CαAla3), 38.6 (CβPhe2), 29.5 (Cprpb), 18.0 (CβAla3), 16.0 (CβAla4); FT-IR ( cm–1) (CH3CN, 2 mM): 3092, 3037, 2603, 2265, 2117, 1880, 1741, 1701, 1639, 1534, 1477, 1245, 1193; HRMS m/z calcd for C23H32N4O7Na 499.2169, found 499.2168.

Acknowledgments

E.N.P. thanks DST-SERB (DSTO1382) for the financial support. S.P. and A.K. acknowledge CSIR and UGC for senior research fellowships. S.B. thanks Indian Institute of Science for fellowship.

Supporting Information Available

The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsomega.0c01277.

  • Detailed synthetic procedures including scales, equivalents of reagents, schemes, and yields; detailed procedures for acquisition of NMR (1D and 2D), CD, FT-IR spectra, and for energy minimization; tables and figures of all of the CD (concentration, temperature, solvent-dependent, etc.); 1D and 2D-NMR spectra, ROE figures and tables; relevant figures, tables, and diagrams to determine the 3D structure of the HBS-constrained macrocyclic peptides (PDF)

The authors declare no competing financial interest.

Supplementary Material

ao0c01277_si_001.pdf (12.1MB, pdf)

References

  1. Chapman R. N.; Dimartino G.; Arora P. S. A highly stable short α-helix constrained by a main-chain hydrogen-bond surrogate. J. Am. Chem. Soc. 2004, 126, 12252–12253. 10.1021/ja0466659. [DOI] [PubMed] [Google Scholar]
  2. Berova N.; Borhan B.; Dong J. G.; Guo J.; Huang X.; Karnaukhova E.; Kawamura A.; Lou J.; Matile S.; Nakanishi K.; et al. Solving challenging bioorganic problems by exciton coupled CD. Pure Appl. Chem. 1998, 70, 377–383. 10.1351/pac199870020377. [DOI] [Google Scholar]
  3. Andrews M. J.; Tabor A. B. Forming stable helical peptides using natural and artificial amino acids. Tetrahedron 1999, 55, 11711–11743. 10.1016/S0040-4020(99)00678-X. [DOI] [Google Scholar]
  4. Hoang H. N.; Wu C.; Hill T. A.; de Araujo A. D.; Bernhardt P. V.; Liu L.; Fairlie D. P. A novel long-range n→π* interaction secures the smallest known α-helix in water. Angew. Chem., Int. Ed. 2019, 58, 18873–18877. 10.1002/anie.201911277. [DOI] [PubMed] [Google Scholar]
  5. Goodman M.; Verdini A. S.; Toniolo C.; Phillips W. D.; Bovey F. A. Sensitive criteria for the critical size for helix formation in oligopeptides. Proc. Natl. Acad. Sci. U.S.A. 1969, 64, 444–450. 10.1073/pnas.64.2.444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Pease J.; Storrs R. W.; Wemmer D. E. Folding and activity of hybrid sequence, disulfide-stabilized peptides. Proc. Natl. Acad. Sci. U.S.A. 1990, 87, 5643–5647. 10.1073/pnas.87.15.5643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Calvo J. C.; Choconta K. C.; Diaz D.; Orozco O.; Bravo M. M.; Espejo F.; Salazar L. M.; Guzman F.; Patarroyo M. E. An alpha helix conformationally restricted peptide is recognized by cervical carcinoma patients’ sera. J. Med. Chem. 2003, 46, 5389–5394. 10.1021/jm030210x. [DOI] [PubMed] [Google Scholar]
  8. Dames S. A.; Martinez-Yamout M.; De Guzman R. N.; Dyson H. J.; Wright P. E. Structural basis for Hif-1α/CBP recognition in the cellular hypoxic response. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 5271–5276. 10.1073/pnas.082121399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kong E.; Pike A.; Hubbard R. Structure and mechanism of the oestrogen receptor. Biochem. Soc. Trans. 2003, 31, 56–59. 10.1042/bst0310056. [DOI] [PubMed] [Google Scholar]
  10. Woody R. W. The exciton model and the circular dichroism of polypeptides. Monatsh. Chem. 2005, 136, 347–366. 10.1007/s00706-004-0279-2. [DOI] [Google Scholar]
  11. Boersma M. D.; Haase H. S.; Peterson-Kaufman K. J.; Lee E. F.; Clarke O. B.; Colman P. M.; Smith B. J.; Horne W. S.; Fairlie W. D.; Gellman S. H. Evaluation of diverse α/β-backbone patterns for functional α-helix mimicry: analogues of the Bim BH3 domain. J. Am. Chem. Soc. 2012, 134, 315–323. 10.1021/ja207148m. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Nataraj D.; Srinivasan N.; Sowdhamini R.; Ramakrishnan C. α-Turns in protein structures. Curr. Sci. 1995, 69, 434–437. [Google Scholar]
  13. Ramakrishnan C.; Nataraj D. Energy minimization studies on α-turns. J. Pept. Sci. 1998, 4, 239–252. 10.1002/(SICI)1099-1387(199806)4:4<239::AID-PSC140>3.0.CO;2-F. [DOI] [PubMed] [Google Scholar]
  14. Chou K. C. Prediction and classification of α-turn types. Biopolymers 1997, 42, 837–853. 10.1002/(SICI)1097-0282(199712)42:7<837::AID-BIP9>3.0.CO;2-U. [DOI] [PubMed] [Google Scholar]
  15. Narita M.; Sode K.; Ohuchi S. Single Amino Acid Preferences for Specific Locations at Type-I α-Turns in Globular Proteins. Bull. Chem. Soc. Jpn. 1999, 72, 1807–1813. 10.1246/bcsj.72.1807. [DOI] [Google Scholar]
  16. Dasgupta B.; Pal L.; Basu G.; Chakrabarti P. Expanded turn conformations: Characterization and sequence-structure correspondence in α-turns with implications in helix folding. Proteins: Struct., Funct., Bioinf. 2004, 55, 305–315. 10.1002/prot.20064. [DOI] [PubMed] [Google Scholar]
  17. Pavone V.; Gaeta G.; Lombardi A.; Nastri F.; Maglio O.; Isernia C.; Saviano M. Discovering protein secondary structures: Classification and description of isolated α-turns. Biopolymers 1996, 38, 705–721. 10.1002/(SICI)1097-0282(199606)38:6<705::AID-BIP3>3.0.CO;2-V. [DOI] [PubMed] [Google Scholar]
  18. Heinlein C. A.; Chang C. Androgen receptor in prostate cancer. Endocr. Rev. 2004, 25, 276–308. 10.1210/er.2002-0032. [DOI] [PubMed] [Google Scholar]
  19. Huang C.-Y.; Klemke J. W.; Getahun Z.; DeGrado W. F.; Gai F. Temperature-Dependent Helix–Coil Transition of an Alanine Based Peptide. J. Am. Chem. Soc. 2001, 123, 9235–9238. 10.1021/ja0158814. [DOI] [PubMed] [Google Scholar]
  20. Frisch M. J.; Trucks G. W.; Schlegel H. B.; Scuseria G. E.; Robb M. A.; Cheeseman J. R.; Scalmani G.; Barone V.; Petersson G. A.; Nakatsuji H.; Li X.; Caricato M.; Marenich A. V.; Bloino J.; Janesko B. G.; Gomperts R.; Mennucci B.; Hratchian H. P.; Ortiz J. V.; Izmaylov A. F.; Sonnenberg J. L.; Williams; Ding F.; Lipparini F.; Egidi F.; Goings J.; Peng B.; Petrone A.; Henderson T.; Ranasinghe D.; Zakrzewski V. G.; Gao J.; Rega N.; Zheng G.; Liang W.; Hada M.; Ehara M.; Toyota K.; Fukuda R.; Hasegawa J.; Ishida M.; Nakajima T.; Honda Y.; Kitao O.; Nakai H.; Vreven T.; Throssell K.; Montgomery J. A. Jr.; Peralta J. E.; Ogliaro F.; Bearpark M. J.; Heyd J. J.; Brothers E. N.; Kudin K. N.; Staroverov V. N.; Keith T. A.; Kobayashi R.; Normand J.; Raghavachari K.; Rendell A. P.; Burant J. C.; Iyengar S. S.; Tomasi J.; Cossi M.; Millam J. M.; Klene M.; Adamo C.; Cammi R.; Ochterski J. W.; Martin R. L.; Morokuma K.; Farkas O.; Foresman J. B.; Fox D. J.. Gaussian 16, revision C.01; Gaussian, Inc.: Wallingford, CT, 2016.
  21. Karle I. L.; Balaram P. Structural characteristics of. alpha.-helical peptide molecules containing Aib residues. Biochemistry 1990, 29, 6747–6756. 10.1021/bi00481a001. [DOI] [PubMed] [Google Scholar]
  22. Fabian H.; Schultz C. P.. Fourier Transform Infrared Spectroscopy in Peptide and Protein Analysis. Encyclopedia of Analytical Chemistry: Applications, Theory and Instrumentation; John Wiley & Sons, Ltd., 2006. [Google Scholar]
  23. Hoang H. N.; Wu C.; Hill T. A.; Dantas de Araujo A.; Bernhardt P. V.; Liu L.; Fairlie D. P. A novel long-range n→π* interaction secures the smallest known α-helix in water. Angew. Chem., Int. Ed. 2019, 58, 18873–18877. 10.1002/anie.201911277. [DOI] [PubMed] [Google Scholar]
  24. Zimm B. H.; Bragg J. Theory of the phase transition between helix and random coil in polypeptide chains. J. Chem. Phys. 1959, 31, 526–535. 10.1063/1.1730390. [DOI] [Google Scholar]
  25. Scholtz J. M.; Baldwin R. L. The Mechanism of alpha-Helix Formation by Peptides. Annu. Rev. Biophys. Biomol. Struct. 1992, 21, 95–118. 10.1146/annurev.bb.21.060192.000523. [DOI] [PubMed] [Google Scholar]
  26. Pace C. N.; Trevino S.; Prabhakaran E.; Scholtz J. M. Protein structure, stability and solubility in water and other solvents. Philos. Trans. R. Soc., B 2004, 359, 1225–1235. 10.1098/rstb.2004.1500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Oancea S.; Formaggio F.; Campestrini S.; Broxterman Q. B.; Kaptein B.; Toniolo C. Distance dependency of exciton coupled circular dichroism using turn and helical peptide spacers. Biopolymers 2003, 72, 105–115. 10.1002/bip.10315. [DOI] [PubMed] [Google Scholar]
  28. Micsonai A.; Wien F.; Kernya L.; Lee Y.-H.; Goto Y.; Réfrégiers M.; Kardos J. Accurate secondary structure prediction and fold recognition for circular dichroism spectroscopy. Proc. Natl. Acad. Sci. U.S.A. 2015, 112, E3095–E3103. 10.1073/pnas.1500851112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Chen Y.; Wallace B. Secondary solvent effects on the circular dichroism spectra of polypeptides in non-aqueous environments: influence of polarisation effects on the far ultraviolet spectra of alamethicin. Biophys. Chem. 1997, 65, 65–74. 10.1016/S0301-4622(96)02225-9. [DOI] [PubMed] [Google Scholar]
  30. Bredehöft J. H.; Jones N. C.; Meinert C.; Evans A. C.; Hoffmann S. V.; Meierhenrich U. J. Understanding photochirogenesis: Solvent effects on circular dichroism and anisotropy spectroscopy. Chirality 2014, 26, 373–378. 10.1002/chir.22329. [DOI] [PubMed] [Google Scholar]
  31. McConnell H. Effect of polar solvents on the absorption frequency of n→ π electronic transitions. J. Chem. Phys. 1952, 20, 700–704. 10.1063/1.1700519. [DOI] [Google Scholar]
  32. Austin R. E.; Maplestone R. A.; Sefler A. M.; Liu K.; Hruzewicz W. N.; Liu C. W.; Cho H. S.; Wemmer D. E.; Bartlett P. A. A template for stabilization of a peptide α-helix: Synthesis and evaluation of conformational effects by circular dichroism and NMR. J. Am. Chem. Soc. 1997, 119, 6461–6472. 10.1021/ja964231a. [DOI] [Google Scholar]
  33. Siedlecka M.; Goch G.; Ejchart A.; Sticht H.; Bierzyǹski A. α-Helix nucleation by a calcium-binding peptide loop. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 903–908. 10.1073/pnas.96.3.903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Hansen A. E.; Bouman T. D. Natural chiroptical spectroscopy: theory and computations. Adv. Chem. Phys. 1980, 545–644. 10.1002/9780470142639.ch5. [DOI] [Google Scholar]
  35. Garcia-Echeverria C.; Chene P.; Blommers M. J.; Furet P. Discovery of potent antagonists of the interaction between human double minute 2 and tumor suppressor p53. J. Med. Chem. 2000, 43, 3205–3208. 10.1021/jm990966p. [DOI] [PubMed] [Google Scholar]
  36. Toniolo C.; Crisma M.; Formaggio F.; Peggion C. Control of peptide conformation by the Thorpe-Ingold effect (Cα-tetrasubstitution). Pept. Sci. 2001, 60, 396–419. 10.1002/1097-0282(2001)60:6<396::AID-BIP10184>3.0.CO;2-7. [DOI] [PubMed] [Google Scholar]
  37. Barth A. Infrared spectroscopy of proteins. Biochim. Biophys. Acta, Bioenerg. 2007, 1767, 1073–1101. 10.1016/j.bbabio.2007.06.004. [DOI] [PubMed] [Google Scholar]
  38. Ghadiri M. R.; Fernholz A. K. Peptide architecture. Design of stable.alpha.-helical metallopeptides via a novel exchange-inert ruthenium(III) complex. J. Am. Chem. Soc. 1990, 112, 9633–9635. 10.1021/ja00182a030. [DOI] [Google Scholar]
  39. Malde A. K.; Zuo L.; Breeze M.; Stroet M.; Poger D.; Nair P. C.; Oostenbrink C.; Mark A. E. An automated force field topology builder (ATB) and repository: version 1.0. J. Chem. Theory Comput. 2011, 7, 4026–4037. 10.1021/ct200196m. [DOI] [PubMed] [Google Scholar]
  40. Stewart J. J. Optimization of parameters for semiempirical methods II. Applications. J. Comput. Chem. 1989, 10, 221–264. 10.1002/jcc.540100209. [DOI] [Google Scholar]
  41. Schmid N.; Eichenberger A. P.; Choutko A.; Riniker S.; Winger M.; Mark A. E.; van Gunsteren W. F. Definition and testing of the GROMOS force-field versions 54A7 and 54B7. Eur. Biophys. J. 2011, 40, 843. 10.1007/s00249-011-0700-9. [DOI] [PubMed] [Google Scholar]
  42. Ruan F.; Chen Y.; Hopkins P. B. Metal ion-enhanced helicity in synthetic peptides containing unnatural, metal-ligating residues. J. Am. Chem. Soc 1990, 112, 9403–9404. 10.1021/ja00181a058. [DOI] [Google Scholar]
  43. Blundell T.; Barlow D.; Borkakoti N.; Thornton J. Solvent-induced distortions and the curvature of α-helices. Nature 1983, 306, 281. 10.1038/306281a0. [DOI] [PubMed] [Google Scholar]
  44. Zhang Q.; Jiang F.; Zhao B.; Lin H.; Tian Y.; Xie M.; Bai G.; Gilbert A. M.; Goetz G. H.; Liras S.; Mathiowetz A. A.; Price D. A.; Song K.; Tu M.; Wu Y.; Wang T.; Flanagan M. E.; et al. Chiral Sulfoxide-Induced Single Turn Peptide α-Helicity. Sci. Rep. 2016, 6, 38573 10.1038/srep38573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Barrow M. J.; Cradock S.; Ebsworth E.; Rankin D. W. Crystal structures of silyl acetate at 150 K and methyl acetate at 145 K, and the molecular structure of silyl acetate in the gas phase. J. Chem. Soc., Dalton Trans. 1981, 1988–1993. 10.1039/dt9810001988. [DOI] [Google Scholar]
  46. Boese A. D.; Kirchner M.; Echeverria G. A.; Boese R. Ethyl Acetate: X-ray, Solvent and Computed Structures. Chem. Phys. Chem. 2013, 14, 799–804. 10.1002/cphc.201200724. [DOI] [PubMed] [Google Scholar]
  47. Albert J. S.; Hamilton A. D. Stabilization of helical domains in short peptides using hydrophobic interactions. Biochemistry 1995, 34, 984–990. 10.1021/bi00003a033. [DOI] [PubMed] [Google Scholar]
  48. Baillargeon P.; Dory Y. L. Supramolecular walls from cyclic peptides: modulating nature and strength of weak interactions. Cryst. Growth Des. 2009, 9, 3638–3645. 10.1021/cg900379n. [DOI] [Google Scholar]
  49. Blackwell H. E.; Grubbs R. H. Highly efficient synthesis of covalently cross-linked peptide helices by ring-closing metathesis. Angew. Chem., Int. Ed. 1998, 37, 3281–3284. 10.1002/(SICI)1521-3773(19981217)37:23<3281::AID-ANIE3281>3.0.CO;2-V. [DOI] [PubMed] [Google Scholar]
  50. Blackwell H. E.; Sadowsky J. D.; Howard R. J.; Sampson J. N.; Chao J. A.; Steinmetz W. E.; O’Leary D. J.; Grubbs R. H. Ring-closing metathesis of olefinic peptides: design, synthesis, and structural characterization of macrocyclic helical peptides. J. Org. Chem. 2001, 66, 5291–5302. 10.1021/jo015533k. [DOI] [PubMed] [Google Scholar]
  51. Modarresi-Alam A. R.; Nowroozi A.; Najafi P.; Movahedifar F.; Hajiabadi H. Conformation analysis and computation of energy barrier to rotation about CN bond in para-methylphenyl carbamate and its solvent dependence in comparison with tertiary carbamates and tertiary amides. J. Mol. Struct. 2014, 1076, 299–307. 10.1016/j.molstruc.2014.07.063. [DOI] [Google Scholar]
  52. Cabezas E.; Satterthwait A. C. The Hydrogen Bond Mimic Approach: Solid-Phase Synthesis of a Peptide Stabilized as an α-Helix with a Hydrazone Link. J. Am. Chem. Soc. 1999, 121, 3862–3875. 10.1021/ja983212t. [DOI] [Google Scholar]
  53. Pellegrini M.; Royo M.; Chorev M.; Mierke D. F. Conformational consequences of i, i+ 3 cystine linkages: nucleation for α-helicity?. J. Pept. Res. 1997, 49, 404–414. 10.1111/j.1399-3011.1997.tb00892.x. [DOI] [PubMed] [Google Scholar]
  54. Jackson D. Y.; King D. S.; Chmielewski J.; Singh S.; Schultz P. G. General approach to the synthesis of short. alpha.-helical peptides. J. Am. Chem. Soc. 1991, 113, 9391–9392. 10.1021/ja00024a067. [DOI] [Google Scholar]
  55. Boal A. K.; Guryanov I.; Moretto A.; Crisma M.; Lanni E. L.; Toniolo C.; Grubbs R. H.; O’Leary D. J. Facile and E-selective intramolecular ring-closing metathesis reactions in 310-Helical peptides: a 3D structural study. J. Am. Chem. Soc. 2007, 129, 6986–6987. 10.1021/ja071148m. [DOI] [PubMed] [Google Scholar]
  56. Patgiri A.; Jochim A. L.; Arora P. S. A hydrogen bond surrogate approach for stabilization of short peptide sequences in α-helical conformation. Acc. Chem. Res. 2008, 41, 1289–1300. 10.1021/ar700264k. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Wang L.; Coric P.; Zhu K.; Liu W.-Q.; Vidal M.; Bouaziz S.; Broussy S. Synthesis and characterization of water-soluble macrocyclic peptides stabilizing protein α-turn. Org. Biomol. Chem. 2018, 16, 459–471. 10.1039/C7OB02852K. [DOI] [PubMed] [Google Scholar]
  58. Wang L.; Liu W.-Q.; Saraux N.; Vidal M.; Broussy S. Solid phase synthesis of constrained 13-membered peptide macrocycles employing Fukuyama–Mitsunobu alkylations. Tetrahedron Lett. 2015, 56, 2456–2459. 10.1016/j.tetlet.2015.03.091. [DOI] [Google Scholar]
  59. Liu J.; Wang D.; Zheng Q.; Lu M.; Arora P. S. Atomic structure of a short α-helix stabilized by a main chain hydrogen-bond surrogate. J. Am. Chem. Soc. 2008, 130, 4334–4337. 10.1021/ja077704u. [DOI] [PubMed] [Google Scholar]
  60. Dimartino G.; Wang D.; Chapman R. N.; Arora P. S. Solid-phase synthesis of hydrogen-bond surrogate-derived α-helices. Org. Lett. 2005, 7, 2389–2392. 10.1021/ol0506516. [DOI] [PubMed] [Google Scholar]
  61. Wang D.; Chen K.; Kulp J. L.; Arora P. S. Evaluation of biologically relevant short α-helices stabilized by a main-chain hydrogen-bond surrogate. J. Am. Chem. Soc. 2006, 128, 9248–9256. 10.1021/ja062710w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Chapman R. N.; Arora P. S. Optimized synthesis of hydrogen-bond surrogate helices: surprising effects of microwave heating on the activity of Grubbs catalysts. Org. Lett. 2006, 8, 5825–5828. 10.1021/ol062443z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Wang D.; Chen K.; Dimartino G.; Arora P. S. Nucleation and stability of hydrogen-bond surrogate-based α-helices. Org. Biomol. Chem. 2006, 4, 4074–4081. 10.1039/B612891B. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Henchey L. K.; Kushal S.; Dubey R.; Chapman R. N.; Olenyuk B. Z.; Arora P. S. Inhibition of Hypoxia Inducible Factor 1α Transcription Coactivator Interaction by a Hydrogen Bond Surrogate α-Helix. J. Am. Chem. Soc. 2010, 132, 941–943. 10.1021/ja9082864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Patgiri A.; Witten M. R.; Arora P. S. Solid phase synthesis of hydrogen bond surrogate derived α-helices: resolving the case of a difficult amide coupling. Org. Biomol. Chem. 2010, 8, 1773–1776. 10.1039/c000905a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Miller S. E.; Thomson P. F.; Arora P. S. Synthesis of Hydrogen-Bond Surrogate α-Helices as Inhibitors of Protein-Protein Interactions. Curr. Protoc. Chem. Biol. 2014, 6, 101–116. 10.1002/9780470559277.ch130202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Joy S. T.; Arora P. S. An optimal hydrogen-bond surrogate for α-helices. Chem. Commun. 2016, 52, 5738–5741. 10.1039/C6CC01104G. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Vernall A. J.; Cassidy P.; Alewood P. F. A Single α-Helical Turn Stabilized by Replacement of an Internal Hydrogen Bond with a Covalent Ethylene Bridge. Angew. Chem., Int. Ed. 2009, 48, 5675–5678. 10.1002/anie.200901059. [DOI] [PubMed] [Google Scholar]
  69. Chin D.-H.; Woody R. W.; Rohl C. A.; Baldwin R. L. Circular dichroism spectra of short, fixed-nucleus alanine helices. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 15416–15421. 10.1073/pnas.232591399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Pace C. N.; Scholtz J. M. A Helix Propensity Scale Based on Experimental Studies of Peptides and Proteins. Biophys. J. 1998, 75, 422–427. 10.1016/S0006-3495(98)77529-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Pal S.; Prabhakaran E. N. Hydrogen bond surrogate stabilized water soluble 310-helix from a disordered pentapeptide containing coded α-amino acids. Tetrahedron Lett. 2018, 59, 2515–2519. 10.1016/j.tetlet.2018.05.029. [DOI] [Google Scholar]
  72. Muñoz V.; Serrano L. Elucidating the folding problem of helical peptides using empirical parameters. Nat. Struct. Mol. Biol. 1994, 1, 399–409. 10.1038/nsb0694-399. [DOI] [PubMed] [Google Scholar]
  73. Shepherd N. E.; Hoang H. N.; Abbenante G.; Fairlie D. P. Single Turn Peptide Alpha Helices with Exceptional Stability in Water. J. Am. Chem. Soc. 2005, 127, 2974–2983. 10.1021/ja0456003. [DOI] [PubMed] [Google Scholar]
  74. de Araujo A. D.; Hoang H. N.; Kok W. M.; Diness F.; Gupta P.; Hill T. A.; Driver R. W.; Price D. A.; Liras S.; Fairlie D. P. Comparative α-Helicity of Cyclic Pentapeptides in Water. Angew. Chem. 2014, 126, 7085–7089. 10.1002/ange.201310245. [DOI] [PubMed] [Google Scholar]
  75. Kauzmann W.; Eyring H. The effect of the rotation of groups about bonds on optical rotatory power. J. Chem. Phys. 1941, 9, 41–53. 10.1063/1.1750824. [DOI] [Google Scholar]
  76. Luidens M. K.; Figge J.; Breese K.; Vajda S. Predicted and trifluoroethanol-induced α-helicity of polypeptides. Biopolymers 1996, 39, 367–376. 10.1002/(SICI)1097-0282(199609)39:3<367::AID-BIP8>3.0.CO;2-M. [DOI] [PubMed] [Google Scholar]
  77. Hoang H. N.; Driver R. W.; Beyer R. L.; Malde A. K.; Le G. T.; Abbenante G.; Mark A. E.; Fairlie D. P. Protein α-Turns Recreated in Structurally Stable Small Molecules. Angew. Chem. 2011, 123, 11303–11307. 10.1002/ange.201105119. [DOI] [PubMed] [Google Scholar]
  78. Hill T. A.; Shepherd N. E.; Diness F.; Fairlie D. P. Constraining Cyclic Peptides To Mimic Protein Structure Motifs. Angew. Chem., Int. Ed. 2014, 53, 13020–13041. 10.1002/anie.201401058. [DOI] [PubMed] [Google Scholar]
  79. Miller S. E.; Kallenbach N. R.; Arora P. S. Reversible α-helix formation controlled by a hydrogen bond surrogate. Tetrahedron 2012, 68, 4434–4437. 10.1016/j.tet.2011.12.068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Susi H.; Timasheff S. N.; Stevens L. Infrared spectra and protein conformations in aqueous solutions I. The amide I band in H2O and D2O solutions. J. Biol. Chem. 1967, 242, 5460–5466. [PubMed] [Google Scholar]
  81. Vass E.; Hollósi M.; Besson F.; Buchet R. Vibrational spectroscopic detection of beta-and gamma-turns in synthetic and natural peptides and proteins. Chem. Rev. 2003, 103, 1917–1954. 10.1021/cr000100n. [DOI] [PubMed] [Google Scholar]
  82. Giannis A.; Rübsam F. Peptidomimetics in drug design. Adv. Drug Res. 1997, 28, 1–78. 10.1016/s0065-2490(97)80013-5. [DOI] [Google Scholar]
  83. Ball J. B.; Andrews P. R.; Alewood P. F.; Hughes R. A. A one-variable topographical descriptor for the β-turns of peptides and proteins. FEBS Lett. 1990, 273, 15–18. 10.1016/0014-5793(90)81040-U. [DOI] [PubMed] [Google Scholar]
  84. Ball J. B.; Hughes R. A.; Alewood P. F.; Andrews P. R. β-Turn topography. Tetrahedron 1993, 49, 3467–3478. 10.1016/S0040-4020(01)90207-8. [DOI] [Google Scholar]
  85. Jackson M.; Mantsch H. H. The use and misuse of FTIR spectroscopy in the determination of protein structure. Crit. Rev. Biochem. Mol. Biol. 1995, 30, 95–120. 10.3109/10409239509085140. [DOI] [PubMed] [Google Scholar]
  86. Starzyk A.; Barber-Armstrong W.; Sridharan M.; Decatur S. M. Spectroscopic evidence for backbone desolvation of helical peptides by 2,2,2-trifluoroethanol: An isotope-edited FTIR study. Biochemistry 2005, 44, 369–376. 10.1021/bi0481444. [DOI] [PubMed] [Google Scholar]
  87. Andrushchenko V. V.; Vogel H. J.; Prenner E. J. Solvent-dependent structure of two tryptophan-rich antimicrobial peptides and their analogs studied by FTIR and CD spectroscopy. Biochim. Biophys. Acta, Biomembr. 2006, 1758, 1596–1608. 10.1016/j.bbamem.2006.07.013. [DOI] [PubMed] [Google Scholar]
  88. Geetha V. Distortions in protein helices. Int. J. Biol. Macromol. 1996, 19, 81–89. 10.1016/0141-8130(96)01106-3. [DOI] [PubMed] [Google Scholar]
  89. Toniolo C.; Benedetti E. The polypeptide 310-helix. Trends Biochem. Sci. 1991, 16, 350–353. 10.1016/0968-0004(91)90142-I. [DOI] [PubMed] [Google Scholar]
  90. Bartlett G. J.; Choudhary A.; Raines R. T.; Woolfson D. N. n→ π* interactions in proteins. Nat. Chem. Biol. 2010, 6, 615–620. 10.1038/nchembio.406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Buckingham A. Chemical shifts in the nuclear magnetic resonance spectra of molecules containing polar groups. Can. J. Chem. 1960, 38, 300–307. 10.1139/v60-040. [DOI] [Google Scholar]
  92. Bellanda M.; Mammi S.; Geremia S.; Demitri N.; Randaccio L.; Broxterman Q. B.; Kaptein B.; Pengo P.; Pasquato L.; Scrimin P. Solvent polarity controls the helical conformation of short peptides rich in Cα-tetrasubstituted amino acids. Chem. – Eur. J. 2007, 13, 407–416. 10.1002/chem.200600719. [DOI] [PubMed] [Google Scholar]
  93. Tonan K.; Ikawa S.-i. Effect of solvent on an NMR chemical shift difference between glycyl geminal α-protons as a probe of β-turn formation of short peptides. Spectrochim. Acta, Part A 2003, 59, 111–120. 10.1016/S1386-1425(02)00115-4. [DOI] [PubMed] [Google Scholar]
  94. Thomas W.NMR and Conformations of Amino Acids, Peptides and Proteins, Annual Reports on NMR Spectroscopy; Elsevier, 1976; pp 1–41.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

ao0c01277_si_001.pdf (12.1MB, pdf)

Articles from ACS Omega are provided here courtesy of American Chemical Society

RESOURCES